Skin Fluorescent Imaging Shows High Sensitivity, Specificity for Discriminating Melanoma Lesions - Summary - MDSpire
Feature

Skin Fluorescent Imaging Shows High Sensitivity, Specificity for Discriminating Melanoma Lesions

Share

Skin fluorescent imaging has demonstrated high sensitivity and specificity in distinguishing between low-risk and high-risk cutaneous lesions, presenting a noninvasive alternative to melanoma biopsies. In a phase II trial involving 240 suspicious lesions across various dermatology clinics, the method showed promising results, with a sensitivity of 93% at a cutoff score of 5 and 87% at a cutoff of 7. Lead author Douglas Grossman, MD, PhD, highlights its potential to improve melanoma detection and reduce unnecessary procedures for patients.

Original Source(s)

Related Content